Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOakley Regulatory News (OCI)

Share Price Information for Oakley (OCI)

Share Price is delayed by 15 minutes
Get Live Data
522.00    2.00 (0.38%)
Bid:
518.00
Ask:
522.00
Spread: 4.00 (0.772%)
Market Cap: £863.73m
OCI Live PriceLast checked at - London Stock Exchange

Intraday Oakley Share Chart

Update from QuotedData

20 Dec 2023 09:39

RNS Number : 4677X
Oakley Capital Investments Limited
20 December 2023
 

 

Oakley Capital Investments - Update from QuotedData

20th December 2023

Walking the walk

Despite broader economic challenges, Oakley Capital Investments (OCI) continues to deliver outstanding, market beating shareholder returns. Its focus on cash-generative companies with recurring revenues and asset-light business models means the portfolio remains well insulated as financial conditions have tightened, highlighted by double digit earnings growth over the last financial year. The staggered nature of its investments has provided a consistent stream of realisations (at an average premium of 35%), validating net asset values (NAVs) and providing plenty of financial flexibility.

The latest of these was the £240m sale of its stake in IU group, which crystalised an 85% IRR. Despite this execution and market leading track record, shares remain at a considerable discount to NAV. While this reflects broader market weakness across unlisted assets, it is difficult to see how it can be justified over the long term given the strength of the company's NAV growth.

Full Research:

https://quoteddata.com/research/oakley-capital-investments-walking-walk-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on Oakley Capital Investments and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUROKROWUUURA
Date   Source Headline
12th Mar 20207:00 amRNSFinal Annual Results 2019
4th Mar 20207:00 amRNSAcquisition of Globe-Trotter
24th Feb 20207:00 amRNSOakley agrees sale of atHome
30th Jan 20207:00 amRNSDirector Dealing
29th Jan 20207:00 amRNSTrading update for the year ended 31 December 2019
24th Dec 20199:00 amRNSUpdate on Rastreator and Acierto
23rd Dec 20193:06 pmRNSHolding(s) in Company
20th Dec 20194:52 pmRNSDirector/PDMR Shareholding
20th Dec 20193:42 pmRNSTransaction in Own Shares
20th Dec 20192:27 pmRNSShare Buy-Back
16th Dec 20197:00 amRNSAppointment of Non-Executive Director
12th Dec 20197:00 amRNSOakley agrees sale of WebPros to CVC
3rd Dec 20197:00 amRNSHolding(s) in Company
15th Nov 20197:00 amRNSDirector Dealing
15th Nov 20197:00 amRNSDirector Dealing
14th Nov 20193:45 pmRNSTransaction in Own Shares
14th Nov 20197:00 amRNSShare Buy-back
18th Oct 20194:58 pmRNSHolding(s) in Company
13th Sep 20197:00 amRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSResults for the six months ended 30 June 19
29th Aug 20197:00 amRNSInvestment in leading design company Alessi
23rd Aug 20198:00 amRNSAdmission to the Specialist Fund Segment
23rd Aug 20197:00 amRNSResult of Annual General Meeting
20th Aug 20195:30 pmRNSOakley Capital Investments
15th Aug 20197:00 amRNSAcquisition of Seven Miles
26th Jul 20197:00 amRNSNotice of AGM
24th Jul 20197:00 amRNSTrading update for the six months ended 30 June 19
18th Jul 20196:11 pmRNSPublication of Prospectus
18th Jul 20197:01 amRNSProposed move to SFS & AIM cancellation
18th Jul 20197:00 amRNSDirectorate Change
20th Jun 201912:50 pmRNSAnnual Report and Accounts and Shares in Issue
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
20th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 20197:00 amRNSDirector/PDMR Shareholding
30th May 20197:00 amRNSInspired welcomes Warburg Pincus as an Investor
13th May 201911:52 amRNSAcquisition of Videotel and Seagull
1st May 20197:00 amRNSAcquisition of stake in Rastreator and Acierto
5th Apr 20192:45 pmRNSHolding(s) in Company
2nd Apr 20192:00 pmRNSKepler Trust Intelligence: New Research
25th Mar 20197:00 amRNSAcquisition of Ekon
15th Mar 20197:00 amRNSTransaction in Own Shares
14th Mar 20197:00 amRNSShare buy-back
14th Mar 20197:00 amRNSAnnual Results for the Year Ended 31 December 2018
6th Mar 20194:53 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSTrading update for the year ended 31 December 2018
3rd Jan 20197:00 amRNSCapital Commitment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.